|
Volumn 47 Suppl 3, Issue , 2008, Pages
|
Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumonia.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BACTERIAL PNEUMONIA;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
CONFERENCE PAPER;
HUMAN;
PRACTICE GUIDELINE;
TREATMENT OUTCOME;
UNITED STATES;
PNEUMONIA;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS AS TOPIC;
COMMUNITY-ACQUIRED INFECTIONS;
GUIDELINES AS TOPIC;
HUMANS;
PNEUMONIA, BACTERIAL;
TREATMENT OUTCOME;
UNITED STATES;
PNEUMONIA;
|
EID: 57749099872
PISSN: None
EISSN: 15376591
Source Type: Journal
DOI: 10.1086/591389 Document Type: Conference Paper |
Times cited : (14)
|
References (0)
|